Secretin is an essential peptide hormone in the human body, playing a critical role in the digestive process. It was first discovered in 1902 by British physiologists William Bayliss and Ernest Starling, marking it as the first hormone to be identified. Secretin is primarily produced in the S-cells of the duodenum, the first segment of the small intestine, and its main function is to regulate the pH of the small intestine's contents.
The mechanism of secretin begins with its release in response to the presence of acidic chyme entering the duodenum from the stomach. When the pH in the duodenum drops below 4.5, the S-cells become activated and secrete secretin into the bloodstream.
Once secretin is released into the bloodstream, it travels to various target organs, exerting its effects through a series of well-coordinated actions. The primary targets of secretin are the pancreas, the liver, and the stomach.
In the pancreas, secretin stimulates the ductal cells to produce and release a bicarbonate-rich fluid into the pancreatic duct, which then flows into the duodenum. This bicarbonate fluid neutralizes the acidic chyme, raising the pH to an optimal level for the activity of digestive enzymes. Without this neutralization, the enzymes from the pancreas, such as amylase, lipase, and proteases, would be less effective in breaking down food particles.
In the liver, secretin enhances the production of bile. Bile is essential for the emulsification and digestion of fats in the small intestine. Secretin-induced bile secretion ensures that fats are adequately broken down and absorbed, maintaining efficient digestion and nutrient absorption.
Secretin also has a regulatory effect on the stomach. It inhibits the secretion of gastric acid by the parietal cells, which helps prevent excessive acidity in the duodenum. By reducing gastric motility and slowing gastric emptying, secretin ensures that the chyme enters the small intestine at a regulated pace, allowing for more efficient digestion and absorption of nutrients.
On a molecular level, secretin exerts its effects by binding to specific receptors on the target cells' surfaces. These receptors are G protein-coupled receptors (GPCRs) known as
secretin receptors. Upon binding to the secretin receptor, a cascade of intracellular events is triggered, involving the activation of
adenylate cyclase and the increase of cyclic adenosine monophosphate (cAMP) levels. This rise in cAMP activates
protein kinase A (PKA), which then phosphorylates various target proteins, leading to the physiological responses observed in the pancreas, liver, and stomach.
In conclusion, secretin plays a pivotal role in maintaining the optimal pH for digestive processes in the small intestine. By stimulating the secretion of bicarbonate from the pancreas, enhancing bile production in the liver, and modulating gastric acid secretion and motility, secretin ensures efficient digestion and nutrient absorption. Understanding the mechanism of secretin not only provides insight into normal digestive physiology but also offers potential therapeutic targets for conditions such as
peptic ulcers,
pancreatitis, and other gastrointestinal disorders.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


